WTI,WT1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ß¦Ã-Çòµ°°×Ѫ֢,hypergammaglobulinemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾ÞÓ׺ìϸ°û,macrocyteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ß°×ϸ°û,HyperleukocyteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
N-¼×»ù-N-ÑÇÏõ»ùëå/MNU,N-methyl-N-nitrosourea/MNUÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾ÞºËϸ°ûÉú³É,megakaryopoiesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ĤÌúתÔ˵°°×,ferroportinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½áÄÚ,nodalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºËÌÒõ«,JugloneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍÑõÓÕµ¼Òò×Ó-1(HIF-1),HEF-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÀÍв´ÜÕ(VP-16),RajiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
MN1»ùÒò,MN1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
GLIPR1,5-ÔÓµª-2'-ÍÑÑõ°ûÜÕ,GLIPR1,5-aza-2'-deoxycitydineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PPAR¦ÃÅäÌå,PPAR¦ÃligandÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔçÓ×Á£Ï¸°û°×Ѫ²¡»ùÒò(PML)±äÒìÌå,Mut-PMLÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ÉÈÜÐ͸Éϸ°ûÒò×Ó,s-SCFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TCR¦ÆÁ´»ùÒò,TCR¦ÆchainÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
AML-M2ÐÎ̬ѧ,AML-M2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸»ÓÚTϸ°û/×é֯ϸ°ûµÄBϸ°ûÁܰÍÁö,T/HRBCLÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
13q14.3λµã,13q14.3situsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û-SELEX,Cell-SELEXÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Tϸ°ûÊÜÌå¦ÃÁ´,¦ÃchainÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
12-Ñõ-Ê®ËÄÍéõ£´¼-13-ÒÒËáõ¥,12-O-tetradecanoylphorbol-13-acetateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ð¤Ä¤Ïà¹ØÁܰÍÁöÒ×λ»ùÒò1,MALT1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
À×Àû¶È°·,lenalidomideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
º£Ãà×´/³¬Éù¼ì²é,cavernous/ultrasonographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
JAK¼Ò×å»ùÒò,JAKsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ûÌ¥ÁöÑÜÉúÉú³¤Òò×Ó-1,Cripto-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×»ù»¯/È¥¼×»ù»¯,methylation/demethylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ó»ÆËØ/Ò©Àíѧ,emodin/pharmacologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËèÑù/°×Ѫ²¡,mgeloid/leukemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ìºÏÆ×ϵ°×Ѫ²¡µ°°×,MLLÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶à·¢ÐÔÄÚ·ÖÃÚ°©µ°°×,MeninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÇÖÊÈܽâ/²¡Òòѧ,Osteolysis/etioloÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
СéÞ°·/ͶҩºÍ¼ÁÁ¿,BERBAMINE/adminÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔ/ÃâÒßѧ,acute/immuonologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦¶¾ËØÀà/Öж¾,enterotoxins/poisoningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϵĤ,MesocolonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°²Ñ¾à¤,AmsacrineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¡´¼5'Á×Ëáø,SIHPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
SNPоƬ,SNP-arraysÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
13ºÅȾɫÌåȱʧ,Del(13q)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½üËı¶Ìå,Near-tetraploidyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Ã-·ÖÃÚøÒÖÖÆ¼ÁDAPT,DAPTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
5-Ï©±û»ù-7-¶þ·ú¼×»ù°×ÑîËØ,5-ally-7-gen-difluormethylenochrysinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¢ÖÃÐÔ×÷ÓÃ,juxtacrineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Tϸ°ûÄÚ¿¹Ô(TIA-1),TIA-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á£-µ¥ºËϸ°û°×Ѫ²¡,MyelomonocyticleukemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥ºËϵ,monocyticÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë«ÓÕµ¼,Bi-inductionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÙ°©,adenocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°©,CarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¨²¬,CarboplatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÊÐÎ,conformalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºçĤ,irisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë÷À·ÇÄá,SorafenibÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°©ÈâÁö,CarcinosarcomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÏ©×Ïɼ´¼,docetaxelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
åçÐÇ,cometÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Â岬,lobaplatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰͽáÇåɨÊõ,LymphadenectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×Ïɼ·Ó,PaclitaxelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ŵµÛ,NordyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉÏÆ¤¸ÆÕ³µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Àä¶³Íâ¿Æ,cryosurgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Ã-ÉäÏß,¦Ã-rayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÎïѧ·Ö²¼,biodistributionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉÏÆ¤Ñù,epithelioidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æ«Àë,deviationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰͽáÇгýÊõ,lymph node excisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ͬ²½·Å»¯ÁÆ,Concurrent chemoradiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÂÈÈ,HyperthermiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Áܰ͹ÜÐγÉ,lymphangiogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÂÁ¢ÐÔ,SolitaryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ezrinµ°°×,EzrinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ûºÏÏß·,CoincidenceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ªÒÆÐÔ,metastaticÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌæÄá²´ß°,TeniposideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¬»·µ°°×,cateninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐûÍþ,XuanweiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÇÈâÁö/²¡Àíѧ,osteosarcoma/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò×Èðɳ,IressaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö§Æø¹Ü³ÉÐÎÊõ,BronchoplastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ëë×°±Ëáµ°°×ø,CaspaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉÏÆ¤Ð͸Æð¤µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍ¹à×¢,hypoperfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ÷Ç¿ÊÊÐÎ,intensity-modulatedÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·´Ïò´«²¥,back propagationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
àßòßøÀà,quinazolinesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
E-cad,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö§Æø¹Ü³ÉÐÎ,BronchoplastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë«»·²¬,dicycloplatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
E¸ÆÕ³µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÄÚÆ¤Éú³¤Òò×Ó-D,VEGF-DÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÏɼÊô,TaxusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¡ÉÏÆ¤Áö,MyoepitheliomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄáĪ˾͡,NimustineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´Ö²Ú,RoughÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RASSF1A»ùÒò,RASSF1A geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰͽáÇгý,LymphadenectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|